CID 139587345

Lacticin 481

Structural Information

Molecular Formula
C127H182N36O35S4
SMILES
CCC(C)C1C(=O)NC2CSCC3C(=O)NC(CSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N/C(=C\C)/C(=O)N3)CC4=CC=CC=C4)C(C)C)CC5=CC=CC=C5)CCC(=O)N)CC6=CNC7=CC=CC=C76)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CSC(C(C(=O)N1)NC(=O)C(CC8=CNC=N8)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)CNC(=O)C(CCCCN)N)C)NC(=O)C(NC(=O)C(NC2=O)CC9=CNC=N9)CCC(=O)O)CC(=O)N)CCSC)CC(=O)N)C(=O)NC(CO)C(=O)O
InChI
InChI=1S/C127H182N36O35S4/c1-12-63(8)101(161-123(193)99(61(4)5)159-97(171)51-138-105(175)85(52-164)141-96(170)50-136-95(169)49-137-104(174)72(129)30-23-24-37-128)124(194)152-82(43-70-48-134-60-140-70)116(186)163-103-65(10)202-58-91-121(191)150-83(44-93(131)167)113(183)145-77(36-38-199-11)109(179)149-84(45-94(132)168)114(184)155-87-54-200-55-88(119(189)153-86(53-165)127(197)198)156-120(190)89(56-201-57-90(158-125(195)102(64(9)13-2)162-126(103)196)118(188)148-81(42-69-47-133-59-139-69)112(182)144-76(108(178)157-91)33-35-98(172)173)154-106(176)73(14-3)142-110(180)78(39-66-25-17-15-18-26-66)151-122(192)100(62(6)7)160-115(185)79(40-67-27-19-16-20-28-67)146-107(177)75(32-34-92(130)166)143-111(181)80(147-117(87)187)41-68-46-135-74-31-22-21-29-71(68)74/h14-22,25-29,31,46-48,59-65,72,75-91,99-103,135,164-165H,12-13,23-24,30,32-45,49-58,128-129H2,1-11H3,(H2,130,166)(H2,131,167)(H2,132,168)(H,133,139)(H,134,140)(H,136,169)(H,137,174)(H,138,175)(H,141,170)(H,142,180)(H,143,181)(H,144,182)(H,145,183)(H,146,177)(H,147,187)(H,148,188)(H,149,179)(H,150,191)(H,151,192)(H,152,194)(H,153,189)(H,154,176)(H,155,184)(H,156,190)(H,157,178)(H,158,195)(H,159,171)(H,160,185)(H,161,193)(H,162,196)(H,163,186)(H,172,173)(H,197,198)/b73-14-
InChIKey
VIEVUPYQRUJFFA-XFKIZFQISA-N
Compound name
2-[[(8Z)-29,35-bis(2-amino-2-oxoethyl)-20-(3-amino-3-oxopropyl)-11,17-dibenzyl-45-butan-2-yl-53-(2-carboxyethyl)-42-[[2-[[2-[[2-[[2-[[2-[[2-[[2-(2,6-diaminohexanoylamino)acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-8-ethylidene-50-(1H-imidazol-4-ylmethyl)-23-(1H-indol-3-ylmethyl)-41-methyl-32-(2-methylsulfanylethyl)-7,10,13,16,19,22,25,28,31,34,37,43,46,48,51,54,61-heptadecaoxo-14-propan-2-yl-3,40,57-trithia-6,9,12,15,18,21,24,27,30,33,36,44,47,49,52,55,60-heptadecazatricyclo[36.9.8.65,26]henhexacontane-59-carbonyl]amino]-3-hydroxypropanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

122
References

37
Patents

2899.245 Da
Monoisotopic Mass

-10.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2900.2523 267.4
[M+Na]+ 2922.2342 267.1
[M-H]- 2898.2377 266.6
[M+NH4]+ 2917.2788 264.8
[M+K]+ 2938.2082 260.0
[M+H-H2O]+ 2882.2423 251.1
[M+HCOO]- 2944.2432 264.7
[M+CH3COO]- 2958.2589 265.5
[M+Na-2H]- 2920.2197 282.6
[M]+ 2899.2445 252.3
[M]- 2899.2455 252.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe